메뉴 건너뛰기




Volumn 13, Issue 5, 2002, Pages 716-720

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase ii study of the italian group for the study of gastrointestinal tract carcinomas (GISCAD)

(21)  Cascinu, S a   Graziano, F b   Ferrau F c   Catalano, V d   Massacesi, C e   Santini, D f   Silva, R R g   Barni, S h   Zaniboni, A i   Battelli, N j   Siena, S k   Giordani, P d   Mari, D g   Baldelli, A M d   Antognoli, S j   Maisano, R l   Priolo, D c   Pessi, M A m   Tonini, G n   Rota, S n   more..


Author keywords

Chemotherapy; Colorectal cancer; Oxaliplatin; Raltitrexed

Indexed keywords

ANTINEOPLASTIC AGENT; OXALIPLATIN; PLATINUM COMPLEX; QUINAZOLINE DERIVATIVE; RALTITREXED; THIOPHENE DERIVATIVE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL;

EID: 0035985287     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf091     Document Type: Article
Times cited : (58)

References (24)
  • 2
    • 0031019918 scopus 로고    scopus 로고
    • Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
    • (1997) J. Clin. Oncol , vol.15 , pp. 808-815
    • de Gramont, A.1    Bosset, J.F.2    Milan, C.3
  • 6
    • 0033103493 scopus 로고    scopus 로고
    • Raltitrexed (Tomudex) in combination treatment for colorectal cancer: New perspectives
    • (1999) Eur. J. Cancer , vol.35 , pp. S1-S2
    • Van Cutsem, E.1
  • 7
    • 0034712536 scopus 로고    scopus 로고
    • Irinotecan combined with fluorouracil compared to fluorouracil alone as first-line treatment for metastatic colorectal cancer. A multicentre randomised trial
    • (2000) Lancet , vol.335 , pp. 1041-1047
    • Douillard, J.Y.1    Cunningham, D.2    Roth, A.D.3
  • 9
    • 0000269364 scopus 로고    scopus 로고
    • Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU+LV) in patients with advanced colorectal cancer (ACC): Results of a randomized, multicenter, North American trial
    • (Abstr 801)
    • (1997) Proc. Am. Soc. Clin. Oncol , vol.16 , pp. 228a
    • Pazdur, R.1    Vincent, M.2
  • 10
    • 0031671255 scopus 로고    scopus 로고
    • Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer
    • Tomudex Colorectal Cancer Study Group
    • (1998) J. Clin. Oncol , vol.16 , pp. 2943-2952
    • Cocconi, G.1    Cunningham, D.2    Van Cutsem, E.3
  • 11
    • 5544237608 scopus 로고    scopus 로고
    • Final results of a randomised trial comparing Tomudex (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
    • 'Tomudex' Colorectal Cancer Study Group
    • (1996) Ann. Oncol , vol.7 , pp. 961-965
    • Cunningham, D.1    Zalcberg, J.R.2    Rath, U.3
  • 17
    • 85021417547 scopus 로고    scopus 로고
    • National Cancer Institute Common Toxicity Criteria. Version 2.0. January 30
    • (1998)
  • 20
    • 0033186036 scopus 로고    scopus 로고
    • A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: Influence of side-effects and administration attributes
    • (1999) Eur. J. Cancer Care (Engl) , vol.8 , pp. 154-161
    • Young, A.1    Topham, C.2    Moore, J.3
  • 21
    • 0033397854 scopus 로고    scopus 로고
    • Quality-of-life assessment in colorectal cancer patients: Evaluation of cancer therapies
    • (1999) Semin. Oncol , vol.26 , pp. 691-696
    • Sprangers, M.A.1
  • 23
    • 0033361084 scopus 로고    scopus 로고
    • An economic comparison of the net clinical benefit and treatment costs of raltitrexed and 5-fluorouracil plus leucovorin (Mayo regimen) in advanced colorectal cancer
    • (1999) J. Med. Econ , vol.2 , pp. 123-132
    • Kerr, D.J.1    O'Connor, K.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.